Cargando…

Self-reported depression among patients with non-small cell lung cancer

BACKGROUND: Lung cancer is a disease with a poor prognosis and psychological impact. Lung cancer causes both physical and psychological burdens on patients, and financial burdens on families and society. The aim of this study was to examine the relationship between depression and influencing factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yan, Gu, Fen, Hou, Li-li, Hu, Yin-qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448394/ https://www.ncbi.nlm.nih.gov/pubmed/26273380 http://dx.doi.org/10.1111/1759-7714.12179

Ejemplares similares

The Effectiveness of Electrical Acupuncture Stimulation in Reducing Levels of Self-reported Anxiety of Lung Cancer Patients during Palliative Care: A Pilot Study
por: HU, Yin-Qing, et al.
Publicado: (2017)

Characterization and selective incorporation of small non-coding RNAs in non-small cell lung cancer extracellular vesicles
por: Li, Chuang, et al.
Publicado: (2018)

The emerging role of circular RNAs in drug resistance of non-small cell lung cancer
por: Yan, Tinghao, et al.
Publicado: (2022)

Safety and Efficacy of Mild Moxibustion on Cancer-Related Fatigue in Non-Small-Cell Lung Cancer Patients Undergoing Chemotherapy
por: Xu, Xiaomin, et al.
Publicado: (2022)

The structural equation model on self-efficacy during post-op rehabilitation among non-small cell lung cancer patients
por: Huang, Fei Fei, et al.
Publicado: (2018)

The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
por: Wang, Fen, et al.
Publicado: (2021)

Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments
por: Chen, Shanshan, et al.
Publicado: (2023)

Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
por: Liu, Guangbo, et al.
Publicado: (2017)

Characterization of non-small cell lung cancer transforming to small cell lung cancer and its response to EGFR-TKI: a case report
por: Fang, Guotao, et al.
Publicado: (2022)

I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-line treatment: a meta-analysis
por: Chen, Zhong-Ke, et al.
Publicado: (2022)

Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer
por: Zhu, Wen-Ting, et al.
Publicado: (2017)

Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer
por: Xie, Xiao-Hong, et al.
Publicado: (2021)

Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer
por: Long, Kaili, et al.
Publicado: (2021)

DISC1 overexpression promotes non-small cell lung cancer cell proliferation
por: Wang, Shuo, et al.
Publicado: (2017)

In Vitro and In Vivo Inhibitory Effect of Gujin Xiaoliu Tang in Non-Small Cell Lung Cancer
por: Hou, Chao, et al.
Publicado: (2018)

let-7 and miR-17 promote self-renewal and drive gefitinib resistance in non-small cell lung cancer
por: Yin, Jun, et al.
Publicado: (2019)

Knockdown of CHPF suppresses cell progression of non-small-cell lung cancer
por: Hou, Xiao-Ming, et al.
Publicado: (2019)

Gemcitabine plus oxaliplatin for the treatment of leptomeningeal metastases of non-small cell lung cancer: A case report and review of the literature
por: BAI, CHONG, et al.
Publicado: (2013)

Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer
por: Feng, Zhenxing, et al.
Publicado: (2022)

Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival
por: Zhou, Chun-Hui, et al.
Publicado: (2012)

Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies
por: Zhu, Qing-Ge, et al.
Publicado: (2017)

Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer
por: Chen, Jibing, et al.
Publicado: (2023)

Expression and significance of SOX2 in non-small cell lung carcinoma
por: Ying, Jie, et al.
Publicado: (2016)

Radiofrequency ablation for stage <IIB non‐small cell lung cancer: Opportunities, challenges, and the road ahead
por: Zhao, Qing, et al.
Publicado: (2023)

Exploratory Study of a CT Radiomics Model for the Classification of Small Cell Lung Cancer and Non-small-Cell Lung Cancer
por: Liu, Shihe, et al.
Publicado: (2020)

Psychometric Properties of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) in Depressed Adolescents
por: Zhang, Wu-Yang, et al.
Publicado: (2020)

Addition of metformin to non‐small‐cell lung cancer patients with or without diabetes
por: Chen, Hua‐Fen, et al.
Publicado: (2022)

Clinicopathological significance of CXCR4 in non-small cell lung cancer
por: Zhou, Xiao-ming, et al.
Publicado: (2015)

Hospital anxiety and depression scale exhibits good consistency but shorter assessment time than Zung self-rating anxiety/depression scale for evaluating anxiety/depression in non-small cell lung cancer
por: Guo, Congying, et al.
Publicado: (2021)

Oroxylin A inhibits the generation of Tregs in non-small cell lung cancer
por: Shen, Le, et al.
Publicado: (2017)

WNT ligands in non-small cell lung cancer: from pathogenesis to clinical practice
por: Xue, Wanting, et al.
Publicado: (2023)

Hypotension from afatinib in epidermal growth factor receptor-mutated non-small cell lung cancer: a case report and literature review
por: Tang, Zhiwei, et al.
Publicado: (2021)

Direct bilirubin levels are prognostic in non-small cell lung cancer
por: Song, Ying-Jian, et al.
Publicado: (2017)

Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents
por: Wang, Yan, et al.
Publicado: (2023)

FIGNL1 promotes non-small cell lung cancer cell proliferation
por: Li, Miao, et al.
Publicado: (2020)

Long-term survival with targeted therapy in an advanced non-small cell lung cancer patient based on genetic profiling
por: Shen, Fang-Fang, et al.
Publicado: (2020)

Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer
por: Song, Xiao-li, et al.
Publicado: (2017)

Modified-Dose Pembrolizumab and Prognostic Outcomes among Non-Small Cell Lung Cancer Patients: A Chart Review Study
por: To, Sheng-Yin, et al.
Publicado: (2022)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer
por: Xie, Xiao-Hong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h44nltog2busoi9abunvsns47c